Basic Information
Everist Genomics Provides Technologies for Diagnosis, Prognosis, and Treatment Selection. Last year, the company launched its first product, OncoDefender-CRC, a prognostic test designed to predict the risk of disease recurrence in patients with early-stage colorectal cancer.
Everist Genomics Inc
Minneapolis,Minnesota,United States of America
less than 15 people
January 01, 2002
--
CustomerService@EveristHealth.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios